Most Americans aren’t familiar with the prescription drug supply chain, but they are familiar with the high costs of medications when they fill a prescription. As Congress examines how medicines move from manufacturer to patients, the questions to explore should be simple: How do we lower launch prices and curb unjustified increases? And how do we increase market competition so we can lower premiums and out-of-pocket costs for patients? Health insurance providers are one of the only checks on